ArticleClinical nephrology2025

Real-world evidence for using urine osmolality as a practical tool in tolvaptan dose optimization in patients with ADPKD.

Andreja Marn Pernat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.